Outset Medical (OM) Depreciation & Amortization (CF) (2019 - 2026)

Outset Medical (OM) has 8 years of Depreciation & Amortization (CF) data on file, last reported at $795000.0 in Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $795000.0, down 38.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.8 million (down 30.92% YoY), and the FY2025 annual result was $4.3 million, down 24.21% from the prior year.
• Depreciation & Amortization (CF) fell to $795000.0 in Q1 2026 per OM's latest filing, from $881000.0 in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $1.5 million in Q2 2023 and troughed at $795000.0 in Q1 2026.
• A 5-year average of $1.3 million and a median of $1.3 million in 2022 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2023 and 2026: Depreciation & Amortization (CF) grew 14.35% in 2023, then plunged 38.56% in 2026.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $1.3 million in 2022, then rose by 13.95% to $1.4 million in 2023, then decreased by 2.77% to $1.4 million in 2024, then plunged by 37.34% to $881000.0 in 2025, then fell by 9.76% to $795000.0 in 2026.
• Business Quant data shows OM's Depreciation & Amortization (CF) at $795000.0 in Q1 2026, $881000.0 in Q4 2025, and $1.0 million in Q3 2025.